Home > Products > CD8 & PSCA > Recombinant Anti-CD8 x Anti-PSCA Bispecific Antibody (Tandem scFv)

Recombinant Anti-CD8 x Anti-PSCA Bispecific Antibody (Tandem scFv)  (BSFV-H302)

Recombinant Anti-CD8 x Anti-PSCA Bispecific Antibody (Tandem scFv) is designed to be expressed as a scFv from an anti-CD8 antibody variable domains fused with a scFv from an anti-PSCA antibody variable domains. It contains a His-tag at the C/N terminus for affinity purification. The BsAb exits as monomer in reducing and non-reducing conditions. This BsAb can retarget T cells to tumor cells. It is designed for the research of Prostate cancer therapy.

Specifications
Targets
CD8 & PSCA
Type
Tandem scFv
Species Reactivity
Human
Target 1
CD8
Host Animal 1
Human
Target 2
PSCA
Host Animal 2
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Prostate cancer
Targets
Target 1
CD8
Gene ID
UniProt ID
Alternative Names
CD8A; CD8a molecule; Cluster of differentiation 8; CD8; MAL; p32; Leu2
Target 2
PSCA
Gene ID
UniProt ID
Alternative Names
PSCA; prostate stem cell antigen; PRO232

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY
Online Inquiry
Please input "biolabs"(case insensitive) as verification code.
USA
45-1 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-381-2994
Fax: 1-631-207-8356
Email:

Europe
Heidenkampsweg 58, 20097 Hamburg, Germany
Tel: 44-207-097-1828
Email:
Related products of "CD8 & PSCA"
45-1 Ramsey Road, Shirley, NY 11967, USA 1-631-381-2994 1-631-207-8356
24x7 CUSTOMER SERVICE
Easy access to products and services you need from our library via
powerful searching tools
© 2007 - 2020 Creative-Biolabs All Rights Reserved.
Distributors
To view the contact information for a specific location,
select your country or region: